• Company
  • News
  • Investors
  • Contacts
  • Careers
polypeptide-logopolypeptide-logologo-mobilepolypeptide-logo
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
✕
  • Home
  • News
  • Expert views
  • Needle-to-needle’: Manufacturing NeoAntigen peptides

Needle-to-needle’: Manufacturing NeoAntigen peptides

28 February 2019
Expert views

Trishul Shah of PolyPeptide Laboratories looks at the prospects for individualised peptide therapeutics* […]

Trishul Shah, Director Business Development,

Speciality Chemicals Magazine, Feb. 2019

Read more

Back to news

Related posts

19 December 2025

PolyPeptide showcases leadership in sustainable peptide manufacturing with two landmark publications

Read more
27 November 2025

PolyPeptide’s Approach to Process Intensification: Tackling the increasing Peptide Demand

Read more
13 August 2025

Backbone Protecting Groups for Enhanced Peptide and Protein Synthesis

Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2026 PolyPeptide Group • Cookie Policy • Sitemap • Privacy policy
    • Company
    • News
    • Investors
    • Contacts
    • Careers